Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control (Q73694872)
Jump to navigation
Jump to search
scientific article published on 01 January 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control |
scientific article published on 01 January 2000 |
Statements
Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control (English)
Diaz-Borjon A
Richaud-Patin Y
Alvarado de la Barrera C
Jakez-Ocampo J
Ruiz-Argüelles A
1 January 2000